Table 3. Results of comparison between NTS group and control group regarding performance of treatment steps in both simulation scenarios
Resuscitation scenario I
Treatment steps NTS Group Control Group Significance
Call for help (yes/no)   Yes: 51.20% No: 48.80% Yes: 35.30% No: 64.70% χ2(1) = 1.94, p = .16
Return of spontaneous circulation (yes/no) Yes: 39.50% No: 60.50% Yes: 32.40% No: 67.60% χ2(1) = 0.42, p = .52
Time until emergency call(s) 303.00 ± 39.90 335.80 ± 41.20 U = 120.00, z = -0.43, p = .68
Time until first defibrillation(s) 184.80 ± 8.60 178.40 ± 11.20 U = 698.50, z = .72, p = .47
Time until return of spontaneous circulation(s) 435.00 ± 26.80 466.00 ± 21.50 t(26) = 0.83, p = .41
Anaphylactic shock scenario II
Treatment steps NTS Group Control Group Significance
Call for help (yes/no) Yes: 46.50% No: 53.50% Yes: 23.50% No: 76.50 % χ2 (1) = 4.33, p = .04
Provided oxygen therapy via non-rebreathing mask (yes/no) Yes: 93.00% No: 7.00% Yes: 94.10% No: 5.90% χ2 (1) = 0.04, p = .85
Adrenaline administration (yes/no) Yes: 48.80% No: 51.20% Yes: 64.70% No: 35.30% χ2 (1) = 1.94, p = .16
Antihistamine administration (yes/no) Yes: 69.80% No: 30.20% Yes: 67.60% No: 32.40% χ2 (1) = 0.04, p = .84
Initiation of blood volume expansion therapy (yes/no) Yes: 55.80% No: 44.10% Yes: 67.60% No: 32.40% χ2 (1) = 1.12, p = .29
Patient´s condition improved (yes/no) Yes: 39.50% No: 60.50% Yes: 38.20% No: 61.80% χ2 (1) = 0.01, p = .91
Time until emergency call(s) 318.40 ± 34.40 356.90 ± 49.90 t(27) = 0.60, p = .55
Time until oxygen administration(s) 152.30 ± 17.20 153.50 ± 18.90 U = 623.50, z = 0.41, p = .69
Time until adrenaline administration(s) 322.50 ± 20.80 336.60 ± 27.30 t(41)= 0.41, p = .69
Time until antihistamine administration(s) 247.20 ± 18.70 189.60 ± 13.90 U = 470.50, z = 2.26, p = .02
Time until initiation of blood volume expansion therapy(s) 219.00 ± 21.00 285.00 ± 21.00 U = 167.50, z = -2.31, p = .02
Time until patient´s condition improved(s) 273.10 ± 13.70 241.80 ± 14.30 t(28)= -1.56, p = .13
Int J Med Educ. 2017; 8:101-113; doi: 10.5116/ijme.58c1.9f0d